What happened
At times, the reason or reasons behind a stock's rise are obscure or mysterious. But that certainly wasn't the case with Collegium Pharmaceutical (NASDAQ:COLL) on Tuesday, which shot 9.8% higher thanks to a development that should dramatically raise its profile.
So what
Collegium, a biotech that has enjoyed success with its pain relief medication Xtampza ER, is about to become a component of the S&P stock index family.
Late Monday, S&P Dow Jones Indices -- the operator of the famous suite of indexes -- announced a change in its benchmark S&P 500 index.
IMAGE SOURCE: GETTY IMAGES.
S&P 500 index component TechnipFMC is getting the boot and being replaced by Monolithic Power Systems. The latter is currently in the S&P MidCap 400 index, so its slot there will be filled by Iridium Communications.
Iridium is now on the S&P SmallCap 600 index, thus a replacement is needed for its position; Collegium is that replacement. The move is slated to take effect this Friday, Feb. 12.
Now what
Inclusion on a notable stock index, particularly one with the characters "S&P" in front of it and particularly for a less-known business like Collegium, instantly raises its visibility. It also, crucially, attracts the many index funds that prowl S&P lineups for their portfolios.
Naturally, greater prominence and attention doesn't necessarily mean an endless stock price lift -- Collegium still has to deliver for shareholders. But this is an extremely positive development for a company that has performed well lately.
Should you invest $1,000 in Collegium Pharmaceutical, Inc. right now?
Before you consider Collegium Pharmaceutical, Inc., you'll want to hear this.
Investing legends and Motley Fool Co-founders David and Tom Gardner just revealed what they believe are the 10 best stocks for investors to buy right now... and Collegium Pharmaceutical, Inc. wasn't one of them.
The online investing service they've run for nearly two decades, Motley Fool Stock Advisor, has beaten the stock market by over 4X.* And right now, they think there are 10 stocks that are better buys.
